‘We’d love to use the cash’: Big pharma’s getting ready to spend tax reform dollars on big deals

Evan Vucci/AP There’s a lot of anticipation for big-ticket pharmaceutical mergers and acquisitions to take off in 2018. That’s in large part because of the tax reform that passed in 2017, which frees up cash companies have overseas and lowers the corporate tax rate.  “We’d love to use the cash to buy and partner to […]

We are witnessing a perfect example of how pharma’s hogs are going to get slaughtered

Reuters/China Stringer Network At a luncheon Thursday, Mallinckrodt Pharma executives said at least one big payer has started putting restrictions on its $ 36,000-a-dose drug called Acthar, a person in attendance told Business Insider. Express Scripts, the giant pharmacy benefit manager, says it is recommending prior authorization for up to a 30-day supply. Continued formulary […]